COVID-19: Read the latest research news and education updates

Einstein Community: Review policies & guidelines and view dashboard.

  • Library
  • Intranet
Albert Einstein College of Medicine
  • About
  • Education
  • Research
  • Departments & Centers
Giving
Search
Menu
Montefiore Health System
  • Faculty Directory
  • Research Connections
  • Faculty Directory
  • Research Connections
Information For
  • Alumni
  • Donors
  • Faculty
  • Postdocs
  • Students (Prospective, Current)
  • Visitors
Quick Links
  • About
  • Administration
  • Departments & Centers
  • Directory
  • Education & Admissions
  • Events
  • Find Faculty
  • Giving
  • Health
  • Intranet
  • Library
  • Research
  • Webmail
News & Media
  • Newsroom
  • Blog
  • Einstein in the News
  • Expert List for Media
  • Features
  • Magazine
  • Multimedia
  • News Releases
  • Research Briefs
  • Social Media Hub

Faculty Profile

  • Home
  • Faculty Directory
  • Joshua D. Nosanchuk, M.D.

Joshua D. Nosanchuk, M.D.

Joshua D. Nosanchuk

Professor, Department of Medicine (Infectious Diseases)

Professor, Department of Microbiology & Immunology

Senior Associate Dean for Medical Education

Area of Research: medical education; assessment; fungal pathogenesis; host-pathogen biology; regenerative medicine; innovative therapeutics

Contact Information

718.430.3371718.430.8825josh.nosanchuk@einsteinmed.edu

Albert Einstein College of Medicine
Jack and Pearl Resnick Campus

1300 Morris Park Avenue
Belfer Building, Room 211
Bronx, NY 10461

Research ProfilesPubMed Portal

Is this your profile? Edit profile

Professional Interests

Medical Education: As Senior Associate Dean for Medical Education, I oversee all aspects of the educational experience of Einstein’s diverse and exceptional medical students. We are continuously striving to innovate our approach to medical education, building upon Einstein’s outstanding basic and translational scientific opportunities, our commitment to community-based programming and team-based active learning, and our rigorous clinical skills experiences. Infused with a humanistic approach to medicine, in which medical students engage in advocacy for their patients, Einstein’s medical training continues to reflect the institution’s mission of promoting social justice and delivering quality care to all. 

I have been privaledged to serve on diverse external education committees, and I am currently on the Executive Board of the National Board of Medical Examiners.

 

Basic Science Laboratory: There are two main areas of research in the Nosanchuk laboratory: fungal pathogenesis and innovative therapeutic development. 

Fungal diseases are a major global health threat, resulting in over 1.5 million deaths annually. A dramatic rise in fungal disease incidence over the past few decades is directly associated with the growing numbers of immunocompromised individuals, particularly patients receiving chemo- or immuno-therapy, recovering from invasive surgery, or individuals with HIV/AIDS. Despite the increased prevalence of mycotic diseases, there remains an enormous gap in knowledge and our current therapeutic armamentarium all too often fails to eradicate these insidious pathogens. The Nosanchuk laboratory is investigating the pathogenesis of human pathogenic fungi, especially Histoplasma capsulatum, Candida parapsilosis, Candida auris and Cryptococcus neoformans. In particular, we are focusing on 1) how antibody can modify disease outcomes and 2) the role of melanin production on pathogenesis. We are also working on deciphering the impact of extracellular release of vesicles from fungi, which contain numerous products associated with virulence.

A second focus area of the laboratory is on innovative approaches to combat 1) fungal infections and 2) wound healing, especially leveraging the delivery of compounds via antibody or nanoparticles. With antibodies, we are using the approach of radioimmunotherapy (labeling antibody with a radionuclide). For fungi, we have identified cell surface antigens that are conserved on diverse fungi in order to develop a “pan-antifungal” therapeutic. In more advanced development, we are using antibodies to melanin for the treatment of melanoma. In collaboration with the laboratory of Dr. David Sharp (Physiology & Biophysics), we are targeting microtubule severing enzymes as a mechanism for tightly regulating cell migration in order to enhance tissue regeneration. In collaboration with Dr. Joel Friedman (Medicine and Physiology & Biophysics) we are exploring diverse applications of a novel, simple and inexpensive nanoparticle platform for drug delivery. We are exploring the therapeutic potential of nitric oxide delivered in sustained release by the nanoparticles for accelerating wound healing as well as for the treatment of diverse infectious diseases, including bacterial and fungal diseases.


Selected Publications

https://pubmed.ncbi.nlm.nih.gov/?term=nosanchuk+j&sort=date

Related News

More News

  • Einstein’s Class of 2023 Celebrates Match Day
    News Release
    Einstein’s Class of 2023 Celebrates Match Day

    Mar 17, 2023

  • Einstein's M.D. Class of 2026 Celebrates at Annual White Coat Ceremony
    News Release
    Einstein's M.D. Class of 2026 Celebrates at Annual White Coat Ceremony

    Aug 24, 2022

  • Propelled by a Pandemic, Incoming Einstein Students Begin Medical Education Journey
    News Release
    Propelled by a Pandemic, Incoming Einstein Students Begin Medical Education Journey

    Aug 18, 2021

  • Einstein Students Win AΩA Leadership Award to Educate Peers and Patients about Vaccines
    News Release
    Einstein Students Win AΩA Leadership Award to Educate Peers and Patients about Vaccines

    Aug 18, 2021

In the News

More Media Coverage

  • Welcome to ID Week, Infection Preventionists

    Infection Control Today - September 27, 2021

    As the annual ID Week conference kicks off, programs chairperson Joshua Nosanchuk, M.D., describes the role of infection preventionists and discusses a range of issues affecting the infectious disease community, including structural determinants of health and the COVID-19 pandemic. Dr. Nosanchuk is senior associate dean for medical education and professor of medicine and of microbiology & immunology at Einstein and an infectious disease specialist at Montefiore.

  • Back to Medical School During COVID-19

    AAMC News - August 11, 2020

    Joshua Nosanchuk, M.D., describes how Einstein medical students are helping to revise select courses in response to the COVID-19 pandemic. Dr. Nosanchuk is senior associate dean for medical education and professor of medicine and of microbiology & immunology at Einstein.

Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
1300 Morris Park Avenue
Bronx, NY 10461
718.430.2000
Affiliated With
Montefiore Health
Yeshiva University
  • About Einstein
    • History
    • Dean's Page
    Administration
    • Administrative Departments
    Alumni
    Careers
  • Centers (Research)
    Contact Us
    Departments
    Diversity
    • Report a Bias Incident
    Donors
    • Giving to Einstein
  • Education
    • Graduate Medical Education (G.M.E.)
    • Graduate Program (Ph.D.)
    • Master of Science in Bioethics (M.B.E.)
    • Master of Science in Clinical Research Methods (M.S.)
    • Medical Program (M.D.)
    • MSTP Program (M.D. - Ph.D.)
  • Einstein Senate
    Faculty Directory
    Health
    • Affiliated Institutions
    • Clinical Programs
    • Global Health
    • E-M Partnership
    INTRANET
    Library
    Luminis Portal
  • Newsroom
    • Blog
    • Einstein in the News
    • Expert List for Media
    • Features
    • Magazine
    • Multimedia
    • News Releases
    • Research Briefs
    • Social Media Hub
  • Policies
    Research
    • Collaboration Zone
    • Scientific Resources
    Video
    Visitors
    • Campus Map
    • Directions
    Webmail
ALBERT EINSTEIN ®
College of Medicine
© Albert Einstein College of Medicine | Privacy Policy | Terms of Use | Webmaster